Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Zur Rose Group AG
  6. Summary
    ROSE   CH0042615283

ZUR ROSE GROUP AG

(ROSE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/27/2021 07/28/2021 07/29/2021 07/30/2021 08/02/2021 Date
342.5(c) 349(c) 343(c) 337(c) 339.5 Last
38 771 37 102 33 720 27 757 26 214 Volume
-1.01% +1.90% -1.72% -1.75% +0.74% Change
More quotes
Estimated financial data (e)
Sales 2021 1 851 M 2 043 M 2 043 M
Net income 2021 -120 M -132 M -132 M
Net Debt 2021 369 M 407 M 407 M
P/E ratio 2021 -27,6x
Yield 2021 -
Sales 2022 2 563 M 2 829 M 2 829 M
Net income 2022 -72,8 M -80,4 M -80,4 M
Net Debt 2022 414 M 457 M 457 M
P/E ratio 2022 -51,4x
Yield 2022 -
Capitalization 3 254 M 3 598 M 3 591 M
EV / Sales 2021 1,96x
EV / Sales 2022 1,43x
Nbr of Employees 1 960
Free-Float 80,7%
More Financials
Company
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and... 
Sector
Drug Retailers
Calendar
08/18Earnings Release
More about the company
Ratings of Zur Rose Group AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ZUR ROSE GROUP AG
07/22ANALYST RECOMMENDATIONS : Barclays, Chevron, Flutter, Netflix, Unilever...
07/22ZUR ROSE GROUP : Jefferies keeps its Buy rating
MD
07/08ZUR ROSE : Octavian Lowers Price Target on Zur Rose Group, Maintains Hold Recomm..
MT
07/07Logitech to Replace Swatch in Two Swiss Indices in September
MT
07/05ZUR ROSE GROUP : Baader Bank reaffirms its Buy rating
MD
06/30ZUR ROSE GROUP : Baader Bank reaffirms its Buy rating
MD
06/25ZUR ROSE GROUP : Gets a Sell rating from UBS
MD
06/17GLOBAL MARKETS LIVE : Microsoft, HSBC, RyanAir, CureVac, Wise...
06/17ZUR ROSE GROUP : UBS reiterates its Sell rating
MD
06/15ZUR ROSE : Names New Chief Technology Officer
MT
06/15ZUR ROSE GROUP STRENGTHENS GROUP MAN : Madhu Nutakki to become Chief Technology ..
PU
06/15EQS-NEWS : Zur Rose Group strengthens Group Management: Madhu Nutakki to become ..
DJ
06/15Madhu Nutakki to Become Chief Technology Officer of Zur Rose Group AG on 1 Au..
CI
06/15ZUR ROSE GROUP STRENGTHENS GROUP MAN : Madhu Nutakki to become Chief Technology ..
PU
06/11ZUR ROSE GROUP : Jefferies keeps its Buy rating
MD
More news
News in other languages on ZUR ROSE GROUP AG
12:31aZURICH STOCK EXCHANGE : 4-Wochenvorschau Schweiz
12:21aCalendrier des semaines 31 à 34 en 2021 (CP, résultats, BNS, etc.)
07/30Morning Briefing - Markt Schweiz
07/30ZURICH STOCK EXCHANGE : 4-Wochenvorschau Schweiz
07/28Morning Briefing - Markt Schweiz
More news
Analyst Recommendations on ZUR ROSE GROUP AG
More recommendations
Chart ZUR ROSE GROUP AG
Duration : Period :
Zur Rose Group AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZUR ROSE GROUP AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 339,50 CHF
Average target price 460,27 CHF
Spread / Average Target 35,6%
EPS Revisions
Managers and Directors
Walter Oberhńnsli Chief Executive Officer & Executive Director
Marcel Ziwica Chief Financial Officer
Stefan Feuerstein Chairman
Bernd Michael Gschaider Chief Operating Officer
Thomas Schneider Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ZUR ROSE GROUP AG19.96%3 564
WALGREENS BOOTS ALLIANCE, INC.18.23%40 784
JD HEALTH INTERNATIONAL INC.-47.33%34 211
MCKESSON CORPORATION17.20%31 526
CARDINAL HEALTH, INC.10.87%17 229
HUADONG MEDICINE CO., LTD38.22%9 611